A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Clinical trial NCT06333821 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06333821
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2030-04-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.